Peptide induced anergy of human allergen-specific T cells.

[1]  G. Aversa,et al.  Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. , 1995, Journal of immunology.

[2]  R. de Waal Malefyt,et al.  Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. , 1995, International immunology.

[3]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[4]  P. Allen,et al.  Th2 cell clonal anergy as a consequence of partial activation , 1994, The Journal of experimental medicine.

[5]  J. Goverman,et al.  T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.

[6]  J. Lamb,et al.  Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes. , 1993, International immunology.

[7]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[8]  J. Greenstein,et al.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Jansen,et al.  T cell epitopes of house dust mite major allergen Der p II. , 1993, Journal of immunology.

[10]  L. Castagnoli,et al.  Regulation of expression of the ligand for CD40 on T helper lymphocytes. , 1993, Journal of immunology.

[11]  B. Wüthrich,et al.  T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. , 1993, Journal of immunology.

[12]  L. Lanier,et al.  Functional expression of B7/BB1 on activated T lymphocytes , 1993, The Journal of experimental medicine.

[13]  D. Sansom,et al.  B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro , 1993, European journal of immunology.

[14]  A. Gaur,et al.  Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. , 1992, Science.

[15]  G. Freeman,et al.  Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.

[16]  J. D. de Vries,et al.  T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. , 1992, Journal of immunology.

[17]  G. Berriz,et al.  Immunodominance: intramolecular competition between T cell epitopes. , 1991, Journal of immunology.

[18]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[19]  R. O’Hehir,et al.  Direct evidence for a functional role of HLA-DRB1 and -DRB3 gene products in the recognition of Dermatophagoides spp. (house dust mite) by helper T lymphocytes. , 1990, International immunology.

[20]  R. Schwartz,et al.  A cell culture model for T lymphocyte clonal anergy. , 1990, Science.

[21]  E. Sercarz,et al.  How some T cells escape tolerance induction , 1989, Nature.

[22]  Lawrence Steinman,et al.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.

[23]  G. Freeman,et al.  B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. , 1989, Journal of immunology.

[24]  E. Appella,et al.  Mechanisms influencing the immunodominance of T cell determinants , 1988, The Journal of experimental medicine.

[25]  J. Lamb,et al.  Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. , 1988, Immunology.

[26]  M. Chapman,et al.  Dust mites: immunology, allergic disease, and environmental control. , 1987, The Journal of allergy and clinical immunology.

[27]  N. Shastri,et al.  The Choice of T‐Cell Epitopes Utilized on a Protein Antigen Depends on Multiple Factors Distant from, as well as at the Determinant Site , 1987, Immunological Reviews.

[28]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[29]  J. Lamb,et al.  Tolerance of T-cell clones is associated with membrane antigen changes , 1983, Nature.

[30]  J. Lamb,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.